Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

EcoVolt Generates Energy from Wastewater

Published: Tuesday, November 26, 2013
Last Updated: Tuesday, November 26, 2013
Bookmark and Share
Researchers bring their invention--the world's first bioelectrically enhanced wastewater to energy system--to market.

Spun out of the Massachusetts Institute of Technology (MIT) in 2006, Cambrian Innovation is commercializing a portfolio of environmental solutions based on newly discovered electrically active microbes. By harnessing the power of bio-electricity and advances in electrochemistry, Cambrian Innovation's products help industrial, agricultural and government customers save money while recovering clean water and clean energy from wastewater streams.

With support from the National Science Foundation (NSF), engineers and co-founders Matt Silver and Justin Buck are bringing their research from the lab to the market. One system, called EcoVolt, generates methane gas from the wastewater by leveraging what is called "electromethanogenesis." It's a newly discovered process for producing methane.

"NSF funding of Cambrian Innovation's research demonstrates our strong interest in supporting small business innovation that leads to novel and greener technological solutions to societal challenges," says NSF program director Prakash Balan.

The EcoVolt system sends wastewater through a bio-electrochemical reactor. As water filters through it, special bacteria in the reactor eat the organic waste in the water and release electrons as a byproduct. Those electrons travel through a circuit to generate methane, or CH4.

A wireless signal allows the process to be monitored remotely. This very high quality methane is then piped out to an engine, where it's burned with a small amount of natural gas. It then generates heat and energy. In addition, sensor systems built by Cambrian Innovation can also monitor pollutants, such as fertilizer run-off.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Emerging and Potentially Harmful Dietary Supplement Adulterant Discovered
The substance, N,alpha-diethylphenylethylamine, has a structure similar to methamphetamine and was found in a consumer dietary supplement product called Craze.
Thursday, October 17, 2013
NSF Grants Enhance Science and Engineering Research Capacity Across the USA
Four projects representing a total of $24 million in new grants aim to inform policy making and address strategic, regional issues.
Wednesday, July 24, 2013
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!